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ABSTRACT

Systemic steroid hormone and intracellular signaling pathways are known to act
cooperatively during the development of vertebrate and invertebrate epithelia. However, the
mechanism of this interaction is poorly understood. Morphogenesis of Drosophila leg imaginal
disc epithelia is regulated both by the steroid hormone 20-hydroxyecdysone (ecdysone) and the
RhoA GTPase signaling pathway. Recent evidence suggests that these pathways act
cooperatively to control imaginal disc morphogenesis. Thus, leg imaginal disc morphogenesis is
an excellent system in which to study the interaction of steroid hormone and intracellular
signaling pathways. We have identified mutations in three genes, 12-5, 18-5, and 31-6, with roles
in the morphogenesis of leg epithelia. Of particular interest, these mutations interact genetically
with each other, mutations in the RhoA signaling pathway, and the ecdysone regulated Sb-sbd
(Stubble) transmembrane serine protease. This suggests that the 12-5, 18-5, and 31-6 gene
products may link hormone and RhoA signaling responses. The goal of this research was to
identify and characterize the 18-5 and 12-5 genes in order to discern the mechanistic relationship
between the RhoA pathway and ecdysone hierarchy.
18-5 and 12-5 were precisely mapped to molecular locations within the Drosophila
genome utilizing a P-element recombination mapping technique. This work narrowed the
location of the 18-5 locus to within an interval of 112 kb within the Drosophila genome
sequence. This interval contains 17 known and predicted genes. I also mapped the location of the
12-5 locus to a 2.6 Mb interval of the 2nd chromosome. Based on phenotypic analyses and the
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site of the molecularly mapped interval, a candidate gene for the 18-5 mutation was identified.
Sequence analysis of the candidate gene was inconclusive and requires further analysis. Genetic
interaction assays indicate that the 18-5 gene product acts upstream or at the level of Rho kinase
in the RhoA signaling pathway.
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INTRODUCTION

Epithelia are one of the four primary tissues and occur in various morphological
types to provide a wide variety of functions. These functions include: secretion,
absorption, and sensation detection as well as the more general structural, protective and
partitioning functions. One of the most important characteristics of epithelia is that cells
adhere to each other to form nearly impermeable, laterally coherent sheets. Several cell
junction types mediate cell-cell interactions in epithelia (e.g. tight junctions, gap
junctions and desmosomes). Adherens junctions are a type of cell junctions which
provide lateral adhesion and tension between epithelial cells to induce sheet formation.
Cadherin and catenin proteins comprise the adherens intercellular junction while
intracellular actin cytoskeletal elements connect neighboring adherens cell junctions
providing tension holding the epithelial sheet together.
The carefully coordinated multistep process of epithelial morphogenesis
contributes to the shape and function of organs and body parts [1]. Examples of epithelial
morphogenesis include embryonic epithelial invagination in the sea urchin, urethral tube
development, and prostate epithelial morphogenesis in humans [2-4]. Specific signals
trigger morphogenetic events and require an accurate coordination of cytoskeletal and
adhesive properties. Through this process, the cell responds to changes in the actin
cytoskeleton with structural alterations that result in a structural reorganization of the
epithelial sheet. Normal development of these tissues is critical for the proper function of
necessary organs, whereas abnormal development of epithilia contributes to
developmental problems and many diseases [5, 6]. Some diseases caused by abnormal
1

epithelial development include: polycystic kidney disease, prostate carcinoma, and
abnormal tubule formation in the mammalian urethra [3, 7, 8]. Understanding the general
mechanisms regulating epithelial morphogenesis is fundamental to the understanding of
the role of epithelial development in various diseases.
Drosophila leg imaginal discs are a congruent system in which to study general
epithelial morphogenesis. Drosophila imaginal primordia give rise to most of the adult
epithelial structures including the adult head, thorax and appendages, and external
genitalia [9]. Imaginal discs arise as invaginations of embryonic epithelium and grow by
mitosis until metamorphosis, at which time, substantial morphological changes occur.
During metamorphosis, nearly all the larval tissues are destroyed by apoptosis, while
concurrently, adult organs and structures are derived from imaginal primordia and
histoblast nests.
Drosophila melanogaster imaginal disc epithelia provide an excellent model to
study the cellular, genetic and molecular biology of the morphogenetic changes in
epithelial sheets. Drosophila leg development is well characterized at a cell biological
level and is highly amenable to genetic analysis. Prior to metamorphosis, leg imaginal
discs are flattened sac-like structures composed of a columnar epithelium on one side,
graded into a thin sheet called the peripodial epithelium and attached by a stalk to the
inner surface of the larval epidermis [9, 10]. Precisely coordinated conformational shape
changes within each epithelial cell stimulates the unfolding and evagination of the leg
disc to form an elongated structure that eventually comprises the adult leg. Leg imaginal
disc morphogenesis is initiated by systemic steroid hormone as well as intracellular RhoA
GTPase signaling [11, 12]. Furthermore, constituent genes of the steroid and RhoA
signaling pathways genetically interact in the developing leg suggesting an intersection
2

between a global steroid hormone response and the ubiquitous intracellular RhoA
signaling pathway to control epithelial morphogenesis. Consequently, Drosophila
imaginal discs make useful tools to study the intersection of hormonal and intracellular
signaling pathways with respect to regulating epithelial morphogenesis.

Ecdysone and Drosophila melanogaster development

All major post-embryonic developmental transitions in Drosophila are controlled
by systemic pulses of the steroid hormone, 20-hydroxyecdysone (hereafter referred to as
ecdysone) [9, 11-14]. The 10 day life cycle of the holometabolous Drosophila
melanogaster consists of discrete embryonic, larval, pupal and adult stages. The larval
period is organized into three instars punctuated by ecdysone-induced molting. At the end
of the third and final instar, a major increase in ecdysone titer causes the progression into
the prepupal stage where the morphogenetic events associated with metamorphosis begin
(Figure 1).
Metamorphosis is divided into two stages: a brief, 12-hour prepupal period and an
84-hour pupal period [9]. The prepupal period begins with pupariation in which the larval
cuticle hardens to form the pupal case and imaginal discs undergo morphogenesis. Adult
head eversion marks the start of the following 84-hour pupal period during which the
adult cuticle is formed and the adult animal ecloses from the pupal case approximately
192 hours after the larva hatches from the egg.
Ecdysone is synthesized in the ring gland of larvae. The ecdysone receptor is a
member of the nuclear hormone receptor family and acts as a heterodimer with another
member of the same family, ultraspiracle [15]. When bound to ecdysteroids, the
heterodimer binds directly to DNA to regulate gene expression and various
3

developmental processes. A similar mechanism is exemplified in mammals in which
estrogen binding to estrogen receptor and estrogen receptor cofactors regulates gene
expression and morphogenesis of mammary ductal formation [16, 17].
Ecdysone pulses occurring in the third larval instar and in prepupae are
developmentally relevant to this thesis. Unlike earlier larval pulses which regulate
molting, late larval and prepupal ecdysone pulses are associated with many tissuespecific responses including leg disc elongation [9]. The low-titer ecdysone pulse at 12
hours post-second/third instar transition stimulates global regulatory gene networks
which control spatial responses in larval tissues and serve to prepare the animal for
metamorphosis. Ecdysone pulses at 48/0 hours and 60/12 hours mark the beginning of
prepupal and pupal periods respectively triggering cell death in most larval tissues and
morphogenesis of adult structures (Figure 1; [13, 14, 18]).

Figure 1: Changes in ecdysone titer at the onset of metamorphosis.
Transient changes in ecdysone titer are indicated. Time 48/0 represents the total time elapsed post
nd

rd

2 to 3 instar molt (48 hours) and the beginning of the prepupal stage (0 hours). Ecdysone pulses regulate
entry into metamorphosis. The initial stages of leg morphogenesis occur during the first six hours of the
prepupal period after pupariation (arrow at 48/0 hours).
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Drosophila leg morphogenesis

Major transformations of the folded leg disc to a tubular leg occur during the first
six hours of prepupal period, while refinements to the structure of the leg, including
segmentation, and the differentiation of hairs and bristles occurs later in the pupal period.
Originally, the imaginal disc cells have an anisometric conformation, with a
greater width than length. In the elongated appendage, the cells become isometric, with
much of their width diminished (Figure 2A; [19]). The result of this shape change is a
lengthening and narrowing of the tubular appendage. Leg disc morphogenesis involves
elongation of the disc and eversion to the outside of the animal, collectively referred to as
evagination (Figure 2B; [9, 10]). The elongation and unfolding of the leg tissue is driven
by the circumferential constriction of the epithelium. Eversion of the appendage to the
outside of the larval epidermis then occurs by widening of the stalks and rupturing of the
peripodial epithelium [9, 20]. These processes are coordinated by precise cell shape
changes caused by the contraction of the apical actin-myosin belt (Figure 2D; [9, 10]).
Bundles of actin microfilaments alternating with myosin II proteins form a ring around
the apical end of each leg disc epithelial cell (Figure 2C and 2D). The myosin proteins
form dimers that, when activated, provide a mechanical force which pulls on the actin
filaments and cell-cell adherens junctions leading to apical constriction and
morphological cell shape changes.
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Figure 2: Illustration depicting the cell shape changes during leg elongation.
(A) The originally anisometric cells take on a more isometric shape through the process of
epithelial morphogenensis. Six hours after pupariation, imaginal epithelia have become isometric. (B) This
reduction in cellular width results in an elongation and narrowing of the tubular structure forming a
rudimentary leg. (C) The morphological cell shape changes are driven by actin-myosin contraction. (D)The
actin myosin belt connects to neighboring epithelial cells at adherens junctions and provides the force
needed for apical circumferential constriction.

Regulation of leg epithelial cell shape changes

A number of genes controlling cell shape changes and presumably actin-myosin
contractility are associated with the proper development of the adult leg and wing. Two
gene groups influencing leg and wing epithelial morphogenesis include the ecdysone
hormone responsive genes and genes that are not directly regulated by ecdysone [11, 12,
21-25]. The Stubble-stubbloid serine protease (Sb-sbd) and broad family of zinc-finger
transcription factors are examples of ecdysone hormone responsive genes which play a
role in leg and wing development [12, 21, 22, 24, 26]. Additionally, non-hormonal
responsive genes including RhoA GTPase and myosin II heavy chain (zipper) are
necessary for normal leg epithelial morphogenesis [23, 27].
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Cell biological analysis has shown that cell shape changes are defective in Sb-sbd
and broad mutants [19, 21]. Animals with mutations in Sb-sbd, broad, RhoA and zipper
exhibit leg and wing malformation phenotypes (Figure 3A and 3B; [12, 23]). This
suggests that the malformed phenotype is a good indicator of failure to alter cell shape, an
essential part of epithelial morphogenesis. In particular, the leg malformation phenotype
is easily scored and characterized by shortened, twisted femurs and bent tibia (Figure
3B). Existing mutations in the genes required for cell shape changes in leg imaginal discs
also provide invaluable research tools which can be used to screen for new genetic
pathway components (see below).

Figure 3: Image depicting the leg and wing wildtype (A and C) and malformed (B and D)
phenotypes.
Wildtype legs are pictured in A, while the malformed leg phenotype is represented by short,
twisted appendages (B). The wildtype wing is shown in C while the typical crumpled, malformed wing is
shown in D [12].

RhoA GTPase signaling in imaginal discs

The Ras superfamily of GTPases are evolutionarily conserved master regulators
of various biological processes. These small 20-25 kDa monomeric signaling proteins,
numbering over 60 in mammals, fall into five major groups; Ras, Rho, Rab, Arf and Ran.
7

The Rho family consisting of Cdc42, Rac and Rho, play a special role in regulating the
actin cytoskeleton [28-30]. In particular, the RhoA (Rho1) gene encodes RhoA-GTPase
which acts as a molecular switch and activates downstream effector kinases. One role of
the effector kinases is the regulation of actin-myosin cytoskeletal contraction and cell
shape changes in many tissues including Drosophila leg and wing epithelial
morphogenesis [31]. In Drosophila, RhoA signaling is involved in developmental
processes as diverse as head involution, dorsal closure, and imaginal disc morphogenesis
[11, 32-34]. Rho proteins are also involved in vertebrate cancers. Studies have shown a
positive correlation between Rho protein levels and breast and testicular cancer diagnosis
[6, 35, 36]. Furthermore, Rho overexpression leads to the detachment of cells from
epithelial sheets in culture [37].
The Rho GTPase protein is active when bound to guanosine triphosphate (GTP)
and inactive when GTP is hydrolyzed to guanosine diphosphate (GDP). This activity is
modulated by guanine nucleotide exchange factors (GEFs) which activate RhoA by
exchanging GDP bound to Rho with GTP. Conversely, GTPase activating proteins
(GAPs) negatively regulate GTPases. GAPs operate by catalyzing the intrinsic GTPase
activity of Rho GTPases to stimulate the hydrolysis of GTP to GDP (Figure 4). Finally,
guanine disassociation inhibitors (GDIs) bind GDP-bound Rho GTPase and hold it in an
inactive state away from the membrane, the normal site of Rho GTPase activity [28].
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Figure 4: The Rho GTPase cycle. Rho GTPases are regulated by GEFs, GAPs and GDIs.
Rho GTPase is activated by the exchange of GDP for GTP by GEFs. Conversely, Rho GTPases
are negatively regulated by the catalysis of the hydrolyzing ability of GTPases by GAPs. GDI proteins bind
GDP-bound RhoGTPase and retain it in an inactive state [28].

RhoGEF2 activates RhoA GTPase which stimulates downstream effector kinases
such as Rho-kinase (Drok) (Figure 5). Rho-kinase phosphorylates myosin light chain
kinase and inactivates myosin light chain phosphatase an enzyme which inhibits myosin
light chain (Sqh) [38]. Phosphorylation of myosin light chain by myosin light chain
kinase and Drok leads to activation of Sqh which in turn activates the myosin II heavy
chain (Zipper) [39]. Activation of Zipper creates tension producing activity resulting in
the contraction of the actin cytoskeleton. Rho-kinase also activates LIM kinase which
phosphorylates and deactivates cofilin. Cofilin is normally dephosporylated and
maintained in an activated state by cofilin phosphatase [40]. Thus, the deactivation of
cofilin and the activation of myosin II heavy chain allows for F-actin polymerization,
cytoskeletal reorganization and contraction. The LIM kinase pathway also results in the
nuclear localization of serum response factor and induced transcription (Figure 5).
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Figure 5: Model of RhoA mediated signaling in imaginal discs.
(see text for discussion).

The downstream activity of the RhoA pathway in the control of cell shape change
in leg development is generally understood, however, the initial activation of RhoA
signaling as well as the interaction between hormonal and intracellular signals driving leg
disc development has not been fully elucidated. Because leg imaginal disc morphogenesis
is absolutely dependent upon hormonal signaling at the onset of pupariation and RhoA
signaling occurs in most if not all tissues, it has been proposed that ecdysone may
temporally regulate RhoA signaling and cell shape changes in developing leg imaginal
discs [12]. Other developmental systems also utilize hormonal activation of intracellular
signaling pathways. An example is that of mammary development in mammals. In the
development of this tissue, estrogen and thryrotropin hormone have each been reported to
10

activate epidermal growth factor receptor and subsequent downstream effectors via a Gprotein-coupled receptor mediated process during ductal morphogenesis in murine
mammary tissue [41, 42].

Stubble serine protease and a proposed regulatory model

One possible mechanistic link between the ecdysone hormone response and RhoA
signaling is the trypsin-like type II transmembrane serine protease (TTSP) Stubble,
encoded by the Stubble-stubbloid (Sb-sbd) gene. The TTSP family is characterized by a
short N-terminal intracellular domain, a transmembrane domain, followed by a variable
stem region which includes a cysteine knot in Stubble, and a C-terminal extracellular
proteolytic domain (Figure 6; [43]).

extracellular
proteolytic
domain

extracellular
stem
region

disulfide knotted domain
plasma membrane

transmembrane domain
intracellular domain

Figure 6: Structure of the Drosophila type II transmembrane serine protease.
(see text for discussion).

There are currently 15 vertebrate and one Drosophila TTSPs described. Many of
the vertebrate TTSPs have been associated with various human pathologies including
colon and breast cancers, renal carcinomas and ovarian cancer [43]. One TTSP in
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humans, the transmembrane protease serine 2 (TMPRSS2) and is regulated by androgenic
hormones and has been shown to be proteolytically auto-activated [44]. Although its
biological functions have not been determined it has been shown that TMPRSS2 is highly
expressed in the epithelium of the human prostate gland and has been implicated in
prostate carcinogenesis [45].
The Stubble mutant is characterized by its shortened bristle phenotype later
attributed to the disorganization of actin bundling [46]. Mutations in this locus also
exhibit leg and wing malformations [12, 19, 22]. Stubble is induced rapidly after
exposure to ecdysone and is essential for cell shape changes during leg morphogenesis.
Sb-sbd mutants interact genetically with several RhoA pathway mutants such as RhoA,
DRhoGEF2, drok, zipper, myosin phosphatase, cofilin phosphatase, and blistered/dSRF
to cause malformed legs (Figure 4) and genetic analysis indicates that Stubble acts
upstream of RhoA [12].
Based on this evidence, a model has been proposed in which temporally and
spatially regulated induction of Stubble by ecdysone results in temporally and spatially
restricted activation of RhoA, and reorganization of the actin cytoskeleton leading to leg
epithelial morphogenesis (Figure 7; [12]). In this model, two possible mechanisms by
which Stubble might activate RhoA are proposed. First, in a mechanism similar to that
demonstrated in TMPRSS2 signaling, proteolytic activation of Stubble could lead to the
activation of a Rho-guanine exchange factor (RhoGEF) via the Stubble intracellular
domain (Figure 7). Second, Stubble might cleave an extracellular molecule such as a
membrane associated receptor leading to activation of RhoA. This mechanism has been
demonstrated also in TMPRSS2 intracellular signaling via proteolytic activation of the Gprotein-coupled receptor PAR2 in the development of the prostate gland [45]. Moreover,
12

trypsin activates a proteolytically activated receptor (PAR) and Stubble is a member of
the trypsin family providing further correlative evidence of the potential for Stubble to
play a role in the proteolytic activation of intracellular signaling [47]. An additional mode
of regulation of Stubble may be accomplished via serine protease inhibitors (Serpins).
Serpins constitute a large family of proteins found in viruses, plants and animals and
function as suicide substrate inhibitors which bind serine proteases and are themselves
cleaved in the process of inhibiting target serine proteases.

Figure 7: Proposed mechanisms regulating the activation of RhoA in imaginal discs:
Stubble, an ecdysone responsive serine protease, activates RhoA via the Stubble intracellular
domain (1). Activation of RhoA could also result from Stubble mediated cleavage of an associated
membrane bound receptor (2).

Genes involved in leg morphogenesis identified in a genetic screen

In order to better understand the relationship between ecdysone and RhoA
signaling during leg development a genetic screen for mutants that interact with Stubble,
RhoA, and zipper mutations was conducted (see below). Six mutants were identified,
three of which are new alleles of RhoA, DRhoGEF2, and zipper. The remaining three
mutations, designated 18-5, 12-5, and 31-6, are all located on the second chromosome
and fully complement other mutations in second chromosome genes known to be
associated with ecdysone and RhoA signaling [12]. Therefore, they represent potentially
13

new genes involved in leg epithelial morphogenesis and their characterization may
improve our understanding of the mechanisms governing the intersection between
ecdysone and RhoA signaling in developing leg epithelia. The 18-5 and 12-5 mutations
are pupal lethals while the 31-6 mutation is semi-lethal with death occurring
predominantly during pupal development (Callis and von Kalm unpublished data).
As a first step toward identifying the 18-5, 12-5, and 31-6 loci, preliminary
genetic mapping studies were performed. Preliminary mapping of the 18-5 gene was
performed using a combination of classical meiotic and deletion mapping. Both
approaches gave consistent results placing the 18-5 gene in the 55D-E cytogenetic region
of the second chromosome which provided a starting point for further work to identify
the gene. Deletion mapping failed to reveal the chromosomal location of the 12-5 and 316 genes. Because the 18-5 and 12-5 mutations exhibit more robust genetic interactions
with Stubble and RhoA than 31-6 (Table 1; [12]), and 18-5 is already mapped to a
relatively small chromosomal region, 18-5 and 12-5 are the primary foci of this thesis.
Collective preliminary data describing the interactions of the 18-5 mutant strongly
indicate a role for the 18-5 gene product in the interaction of the hormone activated
Stubble serine protease and the RhoA signaling pathway during leg morphogenesis
(Table 3; [12]). Bayer et al., (2003) observed robust genetic interactions between 18-5
and 12-5 with Stubble and members of the RhoA pathway. Therefore, considering the
strength of the genetic interactions of the 18-5 and 12-5 mutations with Stubble and
members of the RhoA pathway in developing leg imaginal discs; identification and
characterization of the genes encoding the 18-5 and 12-5 mutations is likely to better our
understanding of the mechanistic relationship between the RhoA pathway and ecdysone
hierarchy.
14

Aims of this thesis

Extensive studies conducted by our lab and others have revealed that ecdysone
mediated and RhoA mediated pathways act in a coordinated effort to regulated imaginal
disc morphogenesis [11, 12, 48, 49]. The goal of this research is to identify and
characterize the 18-5 and 12-5 genes in order to discern the mechanistic relationship
between the RhoA pathway and ecdysone hierarchy. The major findings of the work are
as follows:
1. I mapped the 18-5 and 12-5 genes to precise molecular locations within the
Drosophila genome utilizing a P-element recombination mapping technique. This work
narrowed the location of the 18-5 locus to within an interval of 112 kb within the
Drosophila genome sequence. This interval contains 17 known and predicted genes. I
also mapped the location of 12-5 to a 2.6 Mb interval of the 2nd chromosome.
2. Based on phenotypic analyses, a candidate gene for the 18-5 mutation was
identified. Sequence analysis of the candidate gene in 18-5 homozygotes was
inconclusive and requires further analysis.
3. Genetic interaction assays indicate that the 18-5 and 12-5 mutations interact
with mutations in LIM kinase, Cdc42, and Egfr.
4. A third site suppression analysis was utilized to try to position 18-5 in the
RhoA signaling pathway (Figure 5). Collectively these data place the 18-5 gene product
at the level of or upstream of Rho kinase.

15

MATERIALS AND METHODS

Drosophila crosses

Standard Drosophila crosses were conducted as follows unless specifically noted
otherwise. Drosophila crosses were set up with 4-6 virgin females and 4-5 two-five day
old males in individual vials containing standard cornmeal medium. The adult flies were
allowed to mate at 25°C for four days, at which time, the adults were transferred to a new
vial of medium. The adults were transferred to a third vial on the seventh day following
the initial cross resulting in three total vials from which F1 progeny emerged. Upon day
ten of the mating cross, the adult flies were anesthetized and placed into a container of
mineral oil.
Standard bottle crosses were conducted as follows unless otherwise noted. Flies
were set up in crosses of 30 virgin females and 15 two-five day old males in bottles of
standard laboratory cornmeal medium. The flies were allowed to mate and lay eggs for
four days and subsequently transferred to a fresh bottle. They were again transferred to
fresh bottles on day seven and then the animals were euthanized on day ten. The strategy
resulted in three bottles which contained F1 progeny of the parental cross.
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Deficiency mapping of 18-5 and 12-5

Deletion mapping was conducted by complementation crosses between 18-5 or
12-5 mutants and flies carrying deletions of the region near 55D-E of the second
chromosome. The deficiency mapping was conducted in standard vial crosses. The
resultant mutant/deficiency F1 flies were scored for reduced viability relative to sibling
classes and leg and wing malformation

Molecular mapping of 18-5 and 12-5

In order to molecularly map the 18-5 and 12-5 genes, a P-element recombination
mapping technique was utilized [50]. Briefly, this method entails determining the
recombination distance between a mutation and P-element insertions to the left and right
of a mutation. All P-element insertions used have been molecularly mapped to the
Drosophila genome sequence. This technique permits the calculation of a nucleotide
position between the P-elements corresponding to the location of the desired gene on the
Drosophila genome sequence.

Molecular mapping of the 18-5 mutation:

The P-element recombination mapping technique entails three total crosses
(Figure 8). First, the P1 cross was performed to obtain the necessary females carrying the
P-element and desired mutation in a trans-heterozygous condition (i.e. P, +/+, 18-5). The
P1 cross was conducted in a standard bottle cross.
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Figure 8: This schematic explains the crossing scheme used to conduct the P-element
recombination mapping.
The mapping scheme was adopted for both 18-5 and 12-5 mapping and is shown for the 18-5
mutation. The females carrying both the mutation and the P-element are generated in the first cross.
Following recombination in the F1 females, recombinants were distinguished from non-recombinants in the
F2 cross (see text for discussion). *CyH is a 2nd chromosomal balancer carrying aGMR-Hepsin transgene.
Hepsin is a vertebrate type II transmembrane serine protease and GMR is an eye specific promoter [60].
**CR2 is a 2nd chromosomal balancer which carries a sev-Ras transgene. Ras is a GTPase and sevenless is
an eye specific promoter.

Recombination occurs in the F1 females which were crossed to 185/Curly:Hepsin (CyH) males. The F1 cross was done in a set of 100 separate standard
vial crosses, but altered by using 10 virgin females to increase the density of the
offspring. An additional change to the standard crossing scheme included culturing F1
animals for 4 days at 25°C and then transfer to 18°C so that all white eyed F2 females
could be recovered and crossed as virgins in the third recombination mapping cross.
Approximately 95% of 18-5 homozygotes are either unable to eclose or exhibit
severe wing and leg malformation. However, up to 5% of 18-5 homozygotes “escapers”
do not exhibit any malformation phenotype and appear to be wildtype. This is significant
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in that phenotypically wildtype 18-5, +/+, 18-5 non-recombinants would be scored as
recombinants, thus influencing the molecular mapping calculations. In order to
distinguish the true recombinant +, +/+, 18-5 animals from the non-recombinant
escapers, we tested all F2 white eyed flies to determine if they were recombinants (Figure
9).
All F2 generation white eyed flies were collected as virgins and mated
individually to 4-5 virgin female or two to five day old male 18-5/CR2 animals. In this
cross, the homozygous 18-5 escapers produced either animals carrying the CR2 balancer
or 18-5 homozygotes (Figure 9). However, if the white eyed fly is a recombinant (i.e.
+/18-5), then the resultant progeny contains an additional class of 18-5 heterozygotes
which appear wildtype. This provides a ratio from which we can determine which
animals are true recombinants. The non-recombinant progeny result in a ratio of
approximately two curly wing/rough eyed animals to zero wildtype animals. Conversely,
the F2 recombinants crossed to 18-5/CR2 produce a ratio of approximately two curly
wing/rough eyed progeny to one wildtype class (Figure 9). A set of stringent criteria were
designed for the analysis of F2 crosses in which the results were ambiguous.
1. In order for the F2 progeny to be scored, the CR2 class must have more than
20 animals. If the CR2 class contains less than 20 animals, the data is
excluded from the final calculations.
2. In order for the F2 animal to be deemed a non-recombinant, the CR2/WT ratio
must be >4.00 and malformation frequency must be >30% unless the number
of animals with wildtype eyes is < or = 3.00 or the CR2/WT ratio > 5.00.
However, for CR2/WT ratios that are between 3.00 and 4.00, the total
malformation must be >50%
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3. To be classified as a recombinant: CR2/WT must be <4.00 and mlf must be
<50%
In this manner, I was able to determine which F2 white eyed fly was a
recombinant due to the much greater number of observed wildtype progeny arising from
the F2 recombinant compared to those resulting from the non-recombinant cross.

Figure 9: Strategy for distinguishing white eye F2 non-recombinants from the F2 recombinants.

Molecular mapping of the 12-5 mutation

Molecular mapping of 12-5 was conducted using the P-element recombination
technique described above, but with key modifications to the strategy. First, the crosses
were conducted entirely in bottles of 30 virgin females and 10-15 two-five day old males
and the work was performed entirely at 25°C. Second, because the distances between the
P-elements and 12-5 were for the most part very large, and because the frequency of 12-5
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homozygote escapers is very low, all F2 white eyed animals were considered to be
recombinants. Initial mapping experiments were conducted utilizing a 2nd chromosome
rough mapping P-element mapping kit. The P-element mapping kit is a set of molecularly
defined P-elements specified by the Bellen lab at the University of Baylor and is
available from the Bloomington stock center at the University of Indiana. The insertions
are located at regular intervals along the 2nd and 3rd chromosomes and can be utilized for
P-element recombination mapping [50].

18-5 suppression analysis

Suppression of the 18-5 malformation phenotype was analyzed as described in
Figure 10. The frequency of leg and wing malformations and ectopic crossveins was
compared in RhoA, 18-5, Mbs or ssh and RhoA, 18-5, TM2 triple mutants. These crosses
were set up in sets of 5 vials of 6 virgin female 18-5/CyO,GFP; +/+ and 4-6 two-five day
old males carrying either Mbs3 or ssh. The flies were allowed to breed and lay eggs on
standard cornmeal medium for four days at 25°C. The adults were transferred to new
vials in order to continue egg laying on the 4th and 7th day post-P1 cross. This crossing
strategy provided a total of 15 vials per cross. The adults were then euthanized on day
ten.
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Figure 10: Representative schematic of the suppression analysis crosses.
Image depicts a cross for 18-5 in which the triple mutant for RhoA, 18-5 and Mbs are scored and
compared to the Rho/18-5 mutant lacking the Mbs mutation. Similar experiments were also conducted for
ssh. Only two of the possible F1 progeny classes are shown.

Sequencing of DRal GEFmeso

Extraction of genomic DNA: The 18-5 mutation was rebalanced over CyO
carrying an enhanced yellow fluorescent protein (EYFP). This EYFP is under the control
of the Deformed promoter. Under these conditions, EYFP is strongly expressed in the
mouthparts and spiracles of Drosophila larvae.
Two sets of 20 wandering 3rd instar 18-5 or 12-5 (as progenitor controls)
homozygous larvae were collected based on the lack of EYFP expression. The larvae
were placed into 1.5 mL microcentrifuge tubes, snap frozen in liquid nitrogen and stored
at -80°C. The larvae were homogenized with a motorized pestle in 250 uL of
homogenizing buffer (100 mM Tris-Cl pH 9.1, 50 mM EDTA, 100 mM NaCl, 200 mM
sucrose and 0.5% SDS). After the larvae were completely homogenized, 250 uL of
phenol and 250 uL chloroform were added and the mixture was spun at 14,000 rpm for 5
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minutes at 4°C in an Eppendorf microfuge. The aqueous phase was placed into a new 1.5
mL centrifuge tube and the step was repeated.
Next, the addition of 500 uL of cold 100% ethanol precipitated the DNA and
centrifugation pelleted the sample. The pelleted DNA was precipitated again with 500 uL
of cold 100% ethanol and pelleted at 14,000 rpm for 5 minutes. Finally, the pellet was
washed with 70% ethanol. The pellet was dried in a vacuum centrifuge and resuspended
in 25 ul TE +RNase (0.5ul of 100mg/ml RNase to 25 mL TE).
PCR amplification of GEFmeso: GEFmeso was PCR amplified from 18-5 and
12-5 homozygotes with the use of 12 sets of primers to amplify separate small
overlapping amplifications of approximately 500-700 base pairs in length including the
entire coding region (Table 2).
Table 1: Primers used for the PCR amplification of GEFmeso.
Primer Name

Sequence

Exon1 Forward
Exon1 Reverse
Exon2 Forward
Exon2 Reverse
Exon3 Forward
Exon3 Reverse
Exon4 Forward
Exon4 Reverse
Exon5 Forward
Exon5 Reverse
Exon6 Forward
Exon6 Reverse
Exon7 Forward
Exon7 Reverse
Exon8 Forward
Exon8 Reverse
Exon9 Forward
Exon9 Reverse
Exon10 Forward
Exon10 Reverse
Exon11 Forward
Exon11 Reverse
Exon12 Forward
Exon12 Reverse

CATGTAGACTTTAGATAACAGCGCTG

Fragment size

CCATGTGGATTACGCTGATCCC
GTTGTCATCGCTGTAAATGGCCG
CATGTGCCCTACAAATTCTCACCG
TTCGGGCGAGTAGACTAGGG
CACAAGACGATGCCCAAAAGATAGCC
TTCCGTCTCGTGATCTGGGC
CTGCCGGAGGAGTGAGATACGC
TCTTCGCTCCCTCCTTCACTGC
TGCTAGCTTTAATTGGCCTTCTAACACG
CCGCATGTGCATAACTGTTAGGC
GCCAGGTAAGTGTGGGAGC
ATGATCAGCATGGTGGCGAATAGC
CACACGTACTCTCTGCTTGCCTCC
CACCCAGAATACTAACTAGGTCAGG
GAAAGTCTGGACAGGCTCACCG
CTCTCCGCCAGACTTTCTACGC
GAACAAATCGGTACCAGGCACTCC
ATGCTCTGCTGTGAATCGTACCG
ATGACCAGTCTGCTAGCTACACG
TCAACTGAGCGCCATCCG
ATCAACATTGCAGCACCTCGGTCG
CGTGAGATGTCGCAGTGGGAGC
GACTGATGGCCACGTTCTGACTGGG

23

741
662
611
765
560
675
451
675
705
617
620
562

Amplification of two large introns was omitted; however, intronic regions close to
exons were included to test for possible splice site mutations. The amplification was run
with two thermocycle programs settings. Amplification of eleven of the twelve reactions
was conducted with an annealing temperature of 55°C, while an annealing temperature of
56°C was found to be optimal for exon 11 (Table 3).
Table 2: Thermocycler settings for the PCR amplification of GEFmeso.
55°C
Sample
Exon 1
Exon 2
Exon 3
Exon 4
Exon 5
Exon 6
Exon 7
Exon 8
Exon 9
Exon 10
Exon 12

56°C

Step

Temp.
(in °C)

Denaturation
Annealing
Extention
Cycle numbers
Final Extention
Stop

95
55
72
35x
72
4

Time

Sample
Exon 11

:30
:30
:45

Step
Denaturation
Annealing
Extention
Cycle numbers
Final Extention
Stop

7:00
**

Temp.
(in °C)

Time

95
56
72
35x
72
4

:30
:30
:30
7:00
**

The PCR mixture conditions were constant for all runs (1x buffer, 0.5 uM forward
and reverse primers, 0.8 mM dNTPs, 2.0 mM MgCl2 .1 uL/reaction DMSO, 1 U Sigma
Taq polymerase and 1uL DNA sample). The PCR products were separated on a 0.8%
agarose gel with ethidium bromide (20 ul ethidium bromide to 100 mL agarose gel) for
1.5 hours at 60 volts.
Each gel band containing the desired PCR product was excised from the agarose
gel. The agarose gel containing the PCR product was weighed and incubated with three
volumes of NaI solution at 50°C for five minutes. Next, 5 uL of Geneclean aqueous silica
gel suspension (Qbiogene) was added and the sample was incubated at room temperature
for 10 minutes with intermittent mixing. The silica gel/DNA mixture was pelleted by
centrifugation for one minute at 14,000 rpm. The pellet was washed with “new wash”
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(Tris-amiomethane, Qbiogene) and centrifuged for one minute at high speed. The pellet
was washed two additional times and dried in a vacuum centrifuge for 15 minutes.
Finally, the pelleted silica gel/DNA mixture was washed in 15 uL of purified water and
10 ul of the purified DNA was transferred to a new 1.5 mL microcentrifuge tube.
Cloning: 3.5 uL of each purified PCR product was transferred into a clean 1.5 mL
tube followed by the addition of 1.2 ul of salt solution (1.2 M NaCl, 0.06 M MgCl2) and 4
ng of plasmid vector pCRII-TOPO (Invitrogen). The mixture was incubated at room
temperature for five minutes, then 37°C for ten minutes and transferred to ice. Next, 18 ul
of Oneshot TOP10 chemically competent E. coli (Invitrogen) was added and incubated
for ten minutes before heat shock treatment at 42°C for 30 seconds. This was
immediately followed by the addition of SOC medium (Invitrogen) and shaken at 250
rpm at 37°C for 70 minutes. The cells were then plated onto kanamycin/Xgal plates (50
ug/mL kanamycin, 60 ug/mL Xgal). The colonies were then grown at 37°C overnight and
then placed at 4°C.
Next, white colonies of each plasmid transformation were collected and incubated
in LB broth with ampicilin (50 ug/mL) at 37°C at 250 rpm overnight. The cells were
pelleted at 14,000 rpm for four minutes and then the plasmid DNA was prepared using a
Qiagen Plasmid DNA miniprep kit. Finally, the plasmid DNA was quantified on a
Nanodrop spectrophotometer.
Sequencing: Samples were sequenced at the Interdisciplinary Center for
Biotechnology Research facility at the University of Florida. Sample aliquots were
sequenced with the forward and reverse M13 primers using an automated sequencer
(Perkin Elmer/Applied Biosystems).
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RESULTS

Preliminary genetic interaction data

Preliminary genetic interaction data conducted by Bayer et al., (2003), indicates a
possible role for the 18-5 and 12-5 gene products within the RhoA signaling hierarchy
regulating leg development. The 18-5 mutant exhibits moderate (25-49%) leg
malformation with zipper and Stubble (Table 3). It also interacts strongly (>50%) with
RhoA alleles and Df(2R)Jp8, a deficiency that uncovers RhoA. Additionally, 18-5 exhibits
a moderate interaction with 31-6, a strong interaction with 12-5, and is lethal when
expressed as a homozygote (Table 3). Similarly, genetic data for 12-5 showed that 12-5
also interacts strongly with RhoA and zipEbr mutants and weakly to moderately with
various Stubble alleles (Table 3).

Table 3: 18-5 and 12-5 genetic interactions with ecdysone activated Stubble and members of the
RhoA signaling pathway regulating leg morphogenesis.
All animals are doubly heterozygous for the alleles indicated. The numbers shown indicate the
percentage of animals with malformed legs with the total number of animals scored shown in parentheses.
Reduced viability of 12-5, +/+, 18-5 compared to sibling classes indicated by an * [12].
18-5 and 12-5 genetic interactions
18-5/+
12-5/+
Sb6.3b/+
Sb70/+
RhoAJ3.8/+
RhoAE3.10/+
Df(2R)Jp8/+
zipEbr/+
12-5/+
18-5/+
31-6/+

34 (388)
37 (299)
81 (193)
75 (275)
72 (281)
41 (311)
89 (85)*
Lethal
35 (249)
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17 (229)
39 (257)
94 (148)
93 (125)
78 (209)
71 (186)
Lethal
89 (85)
37 (259)

Deficiency mapping of 18-5

Deficiency mapping localizes the 18-5 gene to 55D2-55E2. Previous deficiency
mapping placed the 18-5 gene in the 55DE cytogenetic region (Callis and von Kalm,
unpublished data). This region is 255 kb and contains 58 known and predicted genes. In
order to identify potential 18-5 candidate genes, higher resolution mapping of the 18-5
mutation was conducted.
Deletion mapping, a technique utilizing deficiencies or regions in which the DNA
is deleted, was conducted to further refine the region containing the 18-5 gene. This was
accomplished by complementation tests between deficiencies and the 18-5 mutation.
Those deficiencies which exhibit lethality, reduced viability and/or a high frequency of
leg malformation are strong candidates to delete the region in which the 18-5 gene is
located. Previous mapping using deficiency, Df(2R)Pu66 narrowed the left boundary to
the 55D2 region while the right boundary of Df(2R)Pu66 remained unclear and defined
as between 55E1 and 56B2. To better define the cytogenetic region containing the 18-5
locus, three additional deficiencies were used to more precisely define the right boundary
of Df(2R)Pu66 (Table 4; Figure 11).
Table 4: This table indicates the results of the complementation tests conducted to more precisely
define the right boundary of Df(2R)Pu66.
Those deficiencies that complement are noted by a +, while those that fail to complement are
represented by a -. ND = not determined.

Deficiency genotype
w1118; Df(2R)Exel7158,
P+PBac{XP5.WH5}Exel7158/CyO
w1118; Df(2R)Exel7157,
P+PBac{XP5.RB3}Exel7157/CyO
W1118; Df(2R)Exel6067, P{XPU}Exel6067/CyO

Bloomington
Stock
number

Deleted
region

7895

55E2-55E10

7894
7549

Df(2R)Pu66

Df(2R)PC4

+

+

-

55E7-55F6

+

+

-

55F8-56A2

+

ND

ND
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18-5

For simplicity during all further discussion Bloomington stock numbers will be
used. Ex7895 overlaps with Df(2R)PC4, but does not overlap with Df(2R)Pu66 (Figure
11). Similarly, Ex7894 deletes a region to the right of the region deleted by Df(2R)Pu66,
and overlaps with Df(2R)PC4. Furthermore, the deficiencies in table 4 complement the
18-5 mutation, indicating that the mutation is located outside of the boundaries defined
by these deficiencies.
The left boundary of Ex7895 is 55E2 and the right boundary of Df(2R)Pu66 has
been previously defined as 55E1-56B2. Therefore, the complementation of Ex7895 and
Df(2R)Pu66 defines the right boundary of Df(2R)Pu66 as 55E1-2. Thus, the 18-5
mutation is located between 55D2 and 55E1-2.

Figure 11: Image depicting the deficiency mapping of 18-5.
The cytogenetic region is listed above the map. The green bar at the bottom represents the 2nd
chromosome. White bars indicate deleted regions that complement 18-5 while those in red do not
complement 18-5.

Many of the breakpoints of Drosophila deficiencies are not well defined, so I
therefore conducted additional experiments to confirm the left and right breakpoints of
Df(2R)Pu66. I used molecularly defined P-element insertions to further map the
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deficiency breakpoints. If a lethal molecularly defined P-element insertion is located
within the deletion, then the animal carrying both the P-element and deficiency will die,
however, if the P-element is outside the deleted region the animal will survive and the
molecular position of the P-element will help to define the endpoint of the Pu66
deficiency. Five molecularly defined lethal P-elements were tested (Table 5; Figure 12).

Table 5: Lethal P-element insertions used to better define the breakpoints of the deficiency,
Df(2R)Pu66.
The P-element insertions were tested for complementation with deficiency Df(2R)Pu66 and were
tested with the much larger deficiency, Df(2R)PC4, to verify the lethality of the P-element insertion. The Pelement insertions that complement the deficiencies are represented by +, whereas those that fail to
complement are represented by -. (* Semi-lethal P-element insertions in which the complementation data is
inconclusive)
Genotype of Stock
Pbac{w[+mC]=RB}CG5189[e01140]/
CyO
P{SUPor-P}CG5226/CyO
P{SUPor-P}KG08199/CyO
P{SUPor-P}KG04591/CyO
y1,w67c23; P{lacW}edlK06602/CyO

Bloomington
Stock number

Cytological
Location

17928
13949
15126
14100
10633

55C9
55D1
55E2
55E6
55E6

Df(2R)Pu66/CR2

Df(2R)PC4/CR2

+
+
+*
+
+*

+*
+*

I will use a nomenclature describing the cytological location of each P-element
for simplification purposes. Transgene insertions P(55C9) and P(55D1) were fully viable
over deficiency Df(2R)Pu66 but were lethal over Df(2R)PC4 (Table 5). This indicates
that the left boundary of Df(2R)Pu66 must be to the right of 55D1 and indicates that the
published cytogenetic boundary of the left side of Df(2R)Pu66 is correct.
P-elements P(55E2) and P(55E6) complemented deficiencies Df(2R)Pu66 and
Df(2R)PC4. The molecular position of P(55E2) and P(55E6) are known to be located
within the breakpoints of the large deficiency Df(2R)PC4. Therefore, since the Pelements are viable over Df(2R)PC4, this suggests that P(55E2) and P(55E6) are semi29

lethal insertions and the data obtained from the respective crosses with Df(2R)Pu66 are
inconclusive. P-element P(55E6) is lethal over Df(2R)PC4, but viable when crossed to
deficiency Df(2R)Pu66. The molecular position of P-element 14100 is 55E6. This
confirms the deletion mapping conducted with deficiency Ex7895 discussed above in
which the right boundary of Df(2R)Pu66 was defined as 55E1-2.
Through this deletion mapping, the region in which the 18-5 locus is located was
further refined to a location between 55D2 and 55E2 (Figure 12). This 140 kb region
contains a total of 32 known and predicted genes and therefore further mapping was
required in order to reduce the number of candidate genes.

Figure 12: Image depicting the P-element insertions used to further define the boundaries of the
deficiency Df(2R)Pu66 used to map 18-5.
Transgene insertions 17928 and 13949 (blue stars) define the upstream boundary of Df(2R)Pu66
while the lethal insertion, 14100 defines the downstream boundary. The P-elements numbered 15126 and
10633 (yellow stars) are semi-lethal.
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Molecular mapping of the 18-5 gene

Molecular mapping defines the location of the 18-5 gene to within a 112 kb
interval of the Drosophila genome. More precise mapping of the 18-5 gene represents a
necessary step toward cloning and gene characterization. To map the 18-5 gene to a more
precise location, I utilized a recently published mapping technique that permits molecular
mapping of a gene on the published genome sequence [50]. This technique has been
shown to be accurate to within 50kb and frequently allows identification of the gene
itself. In this approach, mutations are mapped relative to P-element transposons with
insertion points that have been molecularly defined in the Drosophila genome sequence.
To calculate the precise molecular location of the desired gene, the technique utilizes Pelement insertions located to the left and right of the gene of interest (Figure 13).
Recombination rates between P-elements positioned to the left and right of the desired
mutation and the mutation are used to determine a precise molecular position on the
genome sequence (Figure 13).
An additional benefit of mapping with P-elements is that several thousand Pelement insertions have been mapped to a molecular position in the Drosophila genome.
This allows P-elements close to the mutation of interest to be selected which greatly
improves the accuracy of the technique.
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Figure 13: Schematic depicting the P-element recombination mapping technique.
The known molecular distance (a) between two P-elements (triangles) located to the left and right
of the mutation (asterisk) is utilized to convert the recombination distances between the P-elements and the
mutation into molecular distances between the P-elements and the mutation (b and c). The molecular
distances b and c are used to calculate the precise molecular position of the mutation.

The P-element/18-5 recombination distances were calculated for three P-elements
to the left of 18-5 and one P-element to the right of the mutation (Table 6). Two Pelement insertions referred to as 12921 and 17538 are located less than 800 kb to the left
of the center of Df(2R)Pu66 while 14517 is less than 300 kb to the right of the center of
Df(2R)Pu66 (Table 6). P-element 16573 is located a distance of 3,076 kb to the left of the
center of Df(2R)Pu66. The recombination rates between the P-element insertions and 185 shown in table 6 and Figure 15 have been calculated in centimorgan units. These
recombination distances were utilized in the calculation (see below) of the precise
molecular position of the 18-5 gene.
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Table 6: 18-5/P-element recombination data used to calculate the molecular position of the 18-5
locus.
Three P-element insertions are located to the left of Df(2R)Pu66 while one insertion is located to
the right of Df(2R)Pu66. The distance from the P-element insertion to the center of Df(2R)Pu66 is
indicated in kilobases. The recombination distance (RD) between each insertion and the 18-5 mutaion is
calculated in centimorgan units (cM).

P-element genotype
Left of 18-5
w1118; P{EPgy2}EY03741/
CyO, P{sevRas1.V12}FK1
y1 w67c23; P{SUPorP}KG00600
y1 w67c23; P{EPgy2}
olf186-FEY9167 /In(2L)Gla

Bloomington
stock
number

Molecular
location

Distance from center
of Df(2R)Pu66
(in kb)

18-5/P-element recombination
distance in centimorgans.
(total w- and w+ animals scored)

16573

11,027,098

3,076

8.6 (1188)

12921

13,307,435

798

1.9 (1070)

17538

13,370,071

796

1.8 (1941)

14517

14,350,084

297

1.2 (3063)

Right of 18-5
y1 w67c23; P{SUPorP}KG07142

Calculations: The calculation of the molecular position consists of three general
steps. First, the recombination distances (RD) between the P-elements and the mutation
of interest must be determined in centimorgan units. Second, the RD is then converted
into a projected molecular distance (PMD) measured in base pairs (Figure 14). Third, the
PMD is subsequently added to the nucleotide position of the upstream P-element to
obtain the projected molecular position (PMP) of the gene.
The molecular distance between two P-elements located to the left and right of
18-5 was calculated and divided by the sum of the recombination distances (in cM units)
between each P-element and the mutation. This number (bp/cM) was multiplied by the
distance in cM between the upstream P-element (P1 in figure 13) and 18-5. This projected
molecular distance between P1 and the mutation (PMDb) was added to the known
molecular position of P1 to get the projected molecular position (PMP) of 18-5 within the
Drosophila genome sequence. This procedure was repeated for various P-elements in the
mapping of 18-5.
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Figure 14: This figure shows the formula used to calculate the projected molecular position (PMP)
of the 18-5 mutation.
The projected molecular distance (PMDb) between the upstream P-element (P1 from figure 13) and
the mutation is calculated by converting the recombination distances (RD b and c from figure 13, measured
in centimorgans) of the upstream and downstream P-elements into a molecular distance (PMD) measured
in base-pairs. The PMDb (distance from P1 to mutation) is added to the nucleotide position of the upstream
P-element to identify the precise molecular position of the mutation.

There are two caveats to acknowledge when utilizing this mapping procedure.
The mutation must be a lethal mutation (i.e. homozygotes are inviable) and the Pelements must be as close to the unknown locus as possible which improves the
resolution of the recombination distances. If the mutation is semi-lethal, the homozygous
mutant survivors will appear to be recombinants (see below), thus increasing the
recombination frequency between the P-element and the mutation. Unfortunately, 18-5
presents a complicated challenge because up to 5 % of homozygous animals live to
adulthood. Therefore, in order to map the 18-5 locus, an additional cross (see methods)
was performed to distinguish true F2 generation recombinants from the F2 nonrecombinant homozygous adults.
The molecular mapping data for P-elements 16573, 12921, 17538, and 14517
placed the 18-5 locus within a 37 kb region of the genomic sequence located
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approximately 75 kb to the left of the left breakpoint of Df(2R)Pu66, the smallest
deficiency to uncover 18-5 (Table 6; Figure 15). Given that none of the P-elements tested
on the left were closer than 800 kb to the center of Df(2R)Pu66, it is likely that mapping
error associated with the distance between the P-elements on the right and Df(2R)Pu66
accounts for the discrepancy in location of the 18-5 locus. However, the mapping data do
suggest that 18-5 may be closer to the left end of Df(2R)Pu66.

Figure 15: Image depicting the P-elements (triangles with dashes indicating their respective
positions) used to map the 18-5 gene and the deficiencies defining the smallest mapped region in which the
18-5 gene is located.
The RD value for each 18-5/P-element cross is above each arrow (also noted in table 6). The
mapping data calculated with the RD values places the 18-5 locus within a 37 kb region of the genome
sequence located approximately 75 kb to the left of the left breakpoint of Pu66 (red portion of the
chromosome).

A closer view of the mapping region depicted in figure 16 below shows the 75 kb
difference in the P-element recombination and deletion mapping techniques. Therefore,
taken together, the entire region containing the 18-5 locus mapped using the deletion and
P-element recombination mapping techniques represents a region of approximately 112
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kb. This region contains 17 known or predicted genes as well as possible non-coding
RNAs and siRNAs (Figure 16).

Figure 16: Genomic region in which 18-5 was mapped.
This image shows the three molecular positions of 18-5 mapped by P-element recombination as
well as the deficiency Df(2R)Pu66 as a reference. Position 1 was calculated with P-elements 16573 and
14517. Positions 2 and 3 were calculated with 12921 and 14517, and 17538 and 14517 respectively. This
image represents the smallest region (approximately 112 kb) in which 18-5 is located. The resulting
mapping region contains 17 known or predicted genes (blue bars) as well as many transgene insertions
(triangles) useful for complementation testing with 18-5.

Testing mutations and transgene insertions within the mapped region for
complementation with 18-5

18-5 complements all mutants and transgene insertions in genes available for
testing in the 55D region. The 18-5 gene was mapped to a region of approximately 112
kb. I expanded this interval to a larger area containing 43 known and predicted genes to
be certain not to exclude potential gene candidates. To investigate the possibility that one
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of these 43 genes is allelic to the 18-5 mutation, I conducted complementation tests
between all available mutant alleles and mobile element insertions in the region (table 7).
I complementation tested transgene insertions in 30 of the known or predicted
genes within the region. Those genes which are located in the 112 kb mapped region are
listed in bold in table 7. All of the mobile element insertions that were tested with 18-5
were found to complement the mutation (Table 7).
Table 7: Results of complementation tests between 18-5 and various transgene insertions within or
close to the 112 kb region containing the 18-5 locus.
Genotype of stock
P{SUPor-P}l(2)55Db425-1/CyO
b1 pr1 fs(2)PC4-U133 cn1bw1/CyO
y1 w*; P{lacW}A1-2-54
P{PZ}Prp1907838 cn1/CyO; ry506
P{PZ}l(2)0877008770 cn1/CyO; ry506
w1118; P{GT1}BG02569
y1 w67c23; P{SUPor-P}KG01082
y1 w67c23; P{SUPor-P}KG00319
y1 w67c23; P{SUPor-P}KG01197
y1 w67c23; P{SUPor-P}Eip55EKG02526
y1 w67c23; P{SUPor-P}KG04893
y1 w67c23; P{SUPor-P}KG04987
y1; P{SUPor-P}CG5226KG03347/CyO; ry506
y1 w67c23; P{SUPor-P}CG5224KG05424
y1 w67c23; P{EPgy2}EY00755a
y1 w67c23; P{EPgy2}EY06260

Gene of interest
l(2)55Db
fs(2)PC4-U
Ecol\lacZA1-2-54RA
Prp19
l(2) 08770
Pepck
CG30122
CG30332
CG10927
Eip55E
CG15092
CG30118
CG5226
CG5224
CG10924
CG5226

Bloomington
stock number
4563
6044
10828
12346
12357
12815
13305
13650
13706
13752
13856
13863
13949
14114
15473
15962

Outcome
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement
Complement

w1118; P{EP}SP2637EP2381

SP2637

17246

Complement

Slim

17396

Complement

; P{EPgy2}SP2637
y w
y1 w67c23; P{EPgy2}EY08359

SP2637
CG10927

17427
17454

Complement
Complement

y1 w67c23; P{EPgy2}EY10175

CG30116

17645

Complement

1

67c23

1

67c23

y w

; P{EPgy2}EY07730
EY08074

1118

; PBac{RB}CG33147

CG33147

17884

Complement

1118

; PBac{w[+mC]=RB}GstE7[e01100]

GstE7

17923

Complement

w

w

1118

e00779

e02239

MRpS28

18029

Complement

e03788

w ; PBac{RB}CG10924
w[1118]; PBac{w[+mC]=WH}imd[f02746]

CG10924
Imd

18191
18583

Complement
Complement

w1118; PBac{WH}CG18604f03280

CG18604

18634

Complement

Atg7

19257

Complement

CG33147

19280

Complement

CG5225

19926

Complement

w

; PBac{RB}mRpS28

1118

1118

w

1118

w

1

y w

/CyO

d06996

; P{XP}Atg7

/CyO

; P{XP}CG33147

d07752

67c23

EY08313

; P{EPgy2}CG5224
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18-5 genetic interactions

18-5 interacts genetically with 12-5, RhoA, Cdc42, Lim kinase and Egfr, but
not with blistered, Ral GTPase, Ral-like protein, Ral guanine nucleotide exchange
factor 2, or p21 activated kinase. 18-5 homozygotes exhibit leg and wing malformation
phenotypes characteristic of mutations in genes of the RhoA signaling pathway as well as
ecdysone activated Stubble mutants (Table 8). 18-5 homozygotes often exhibit the
characteristic leg malformations represented by shortened, twisted femurs (67%). The
wing of 18-5 homozygotes exhibits 81% overall malformation. The overall wing
malformation can be further separated into general wing malformations including
crumpled or blistered wings (50%) and wings expressing ectopic crossveins (31%).
Standard vial crosses were conducted in order to better characterize the genetic
interactions between mutant alleles of various genes and 18-5 (Table 8). Genetic
interactions of 18-5 were analyzed with second-site non-complementation tests between
18-5 and mutations in genes which are proposed to play a role in wing and/or leg
development. Briefly, second-site non-complementation is defined as the crossing of two
animals with genes at differing loci which results in trans-heterozygote offspring that
exhibit the malformed phenotype typically observed in the homozygotes. Moreover, this
non-complementation of two genes reflects a functional connection between differing
gene products.
The 18-5 ectopic crossvein phenotype is of interest to this study because
mutations in genes such as18-5, RhoA, Sb, Lim kinase, Cdc42, and Rala have been shown
to exhibit ectopic wing crossveins, thereby suggesting a possible functional relationship
between the gene products (Table 8; [48, 51-53]). As heterozygotes, 18-5 mutants do not
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exhibit either leg or wing malformation. However, as trans-heterozygotes carrying 18-5,
several genes were shown to interact genetically with 18-5 and exhibit leg and/or wing
developmental malformations (Table 8). The genes which interact with 18-5 especially
regarding crossvein development include; LIM kinase (8%), RhoA72O (19%), Cdc42 (953%), and 12-5 (43%) (Table 8), moreover, these mutants do not exhibit ectopic
crossveins as heterozygotes.
The ectopic crossvein phenotype is important because it is expressed by mutations
in genes such as RhoA, Sb and LimK which play a significant role in the morphogenesis
of the leg and wing. The ectopic vein is most often seen between longitudinal veins three
and four and between the anterior and posterior crossveins (Figure 17). The ectopic
crossvein seen in figure 17 is the additional crossvein most often observed, although,
there are often ectopic crossveins in other areas of the wing as well as additional
crossveins which remain incomplete and do not reach across the intravein space.

Figure 17: Wing malformation phenotype depicting the extra crossvein.
The photo on the left is of a wildtype wing, note the anterior wing crossvein (AC left, small) and
the posterior crossvein (PC right, wider). The image on the right is wing from a +, Cdc424; +/18-5 animal
with an extra crossvein appearing between longitudinal veins three (L3) and four (L4) and between anterior
(AC) and posterior (PC) crossveins
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Other genes were tested with 18-5 to investigate their prospective roles in wing
vein development (Table 8). These include the genes; blistered (bs), Rala GTPase (Rala),
Ral-guanine nucleotide exchange factor 2 (Rgl), and Ral-like protein (rlip). Interestingly,
none of the trans-heterozygotes carrying one copy of 18-5 and one copy of the indicated
allele exhibited any malformation including ectopic wing crossveins (Table 8). Blanke
and Jackle (2006) showed that a dominant negative Ral GTPase under the control of an
en-Gal4 driver resulted in additional but incomplete crossveins [53], but interestingly, the
Rala mutants I tested with 18-5 did not exhibit any malformations as a trans-heterozygote
with 18-5 (Table 8).
Blanke and Jackle (2006) recently showed that RNAi knockdown of GEFmeso (a
Ral guanine nucleotide exchange factor), resulted in the induction of additional
crossveins. Similar ectopic crossveins in the wing are also exhibited in dominant negative
and loss of function Cdc42 mutations and Lim kinase mutants [48, 51-53]). Significantly,
GEFmeso is located within the mapped interval defining the location of the 18-5 gene
(CG30115 in figure 16).
Taken together, this genetic data, along with the location of GEFmeso within the
mapped interval of 18-5, makes GEFmeso a realistic candidate for the location of the 185 mutation locus.
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Table 8: Genetic interactions of 18-5.
All stocks shown were crossed to 18-5/CR2 and the trans-heterozygotes carrying the 18-5
mutation and the mutation in the gene of interest were scored for leg and wing malformation. Numbers
indicate the percent malformation observed in the trans-heterozygotes (number in parentheses indicates the
total animals and wings scored).

Malformation

Genotype of stock or cross
(Oregon R)+/+
18-5/CR2
Df(2R)PC4/CR2
w, 12-5/CyH

Gene of
interest
Wildtype
18-5
18-5
12-5

Leg malformation
(total animals
scored)
0 (71)
67 (24)
71 (45)
17 (106)

Rho72O/CR2

RhoA

50 (71)

33

19

52 (142)

blistered

0 (97)

0

0

0 (194)

bw[1] bs[ba]
1

3

1

3

Crumpled
wing
0
50
35
46

Ectopic
crossveins
0
31
29
43

Wing total (total
wings scored)
0 (142)
81 (48)
64 (90)
89 (212)

px , bs / px , bs
y w; P{w[+mC]=lacW}bs
[k07909]/CyO

blistered

0 (118)

0

0

0 (236)

blistered

0 (96)

0

0

0 (192)

y,w{P[Limk1,EYO8757]}

LimK

1 (399)

3

8

11 (798)

Pak6/TM3,Sb1
Pak11/TM3,Sb1

Pak
Pak

0 (44)
0 (30)

0
0

0
0

0 (88)
0 (60)

y1, w*, Cdc421/FM6

Cdc42

0 (44)

0

41

41 (88)

1

2

Cdc42

0 (48)

4

9

13 (96)

1

3

y ,w*,Cdc42 /FM6

Cdc42

0 (48)

0

53

53 (96)

y,w,Cdc424P{ry[+t7.2]}/FM6

Cdc42

0 (12)

0

17

17 (24)

w67C23 P{lacW}RalaG0501/ FM7c

Rala

0 (84)

0

0

0 (168)

y ,w*,Cdc42 P{neoFRT}19A

67C23

w

G0174

/ FM7c

Rala

0 (29)

0

0

0 (58)

w67c23 P{lacW}RalaG0373/ FM7c

Rala

0 (31)

0

0

0 (62)

P{GT1}RglBG02025/ TM3,Sb1,Ser1
Pbac{Rgl}

Rgl
Rgl

0 (48)
0 (43)

0
0

0
0

0 (98)
0 (86)

w[1118]; PBac{w]}Rlip[c02656]
Df(3r)Exe16272(Rlip)/TM6B

Rlip
Rlip

0 (29)
2 (55)

0
0

0
0

0 (58)
0 (110)

Df(2R)Egfr18, b[1] pr[1]
cn[1]/CyO, bw[1]

Egfr

3 (37)

3

0

3 (74)

Egfr
Egfr

0 (30)
0 (46)

0
0

0
0

0 (60)
0 (92)

Egfr
Egfr

0 (51)
0 (34)

0
0

0
0

0 (102)
0(68)

t1

P{lacW}Rala

1

Egfr bw /CyO
cn[1] Egfr[f2] bw[1] sp[1]/CyO
Egfr[f24]/T(2;3)TSTL, CyO:
TM6B, Tb[1]
y w; P{wlacW}Egfr/CyO
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Sequencing of DRal GEFmeso in 18-5 homozygotes

A candidate gene located within the region in which 18-5 is located is the gene
encoding GEFmeso (CG30115 in figure 16). GEFmeso encodes a guanine exchange
factor which regulates the Ral GTPase and has also been shown to bind the Rho family
member Cdc42. Moreover, RNAi experiments targeting GEFmeso have been shown to
exhibit an ectopic crossvein wing phenotype similar to that of 18-5 [53].
GEFmeso is a guanine nucleotide exchange factor identified as a Ral GTPase
activator. The protein has two isoforms, GEFmeso (1237 amino acids) and GEFmesoshort (731 amino acids) (Figure 18, [53]). The GEFmeso-short lacks the Dbl-homology
(DH) and Pleckstrin homology (PH) domains found in GEFmeso. The DH domain is
responsible for the catalytic activity driving the GDT-GTP exchange within GTPases,
while the PH domain binds lipids and is necessary for membrane localization to occur.
GEFmeso also contains a Ral GTPase binding region (RBR) and other protein domains
including putative PEST and PDZ motifs as well as several proline rich regions. The PDZ
domain is most likely required for protein-protein interactions [54].

Figure 18: Schematic of GEFmeso structure [53]
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To investigate the possibility that GEFmeso is 18-5; I cloned and sequenced
GEFmeso from 18-5 and 12-5 (as a progenitor control) homozygotes. To accomplish this,
I used 24 forward and reverse primers to PCR amplify the coding region of the gene
(Table 2). The primers amplified the coding region in 500-700 bp fragments and all
primers overlapped by an average of 150 bp for complete coverage. Two large introns
between primers 5 and 6 and between 8 and 9 were omitted (Figure 19), but the PCR
amplification extended into the intron to include possible splice site mutations.

Figure 19: Locations of primers used for the PCR amplification of GEFmeso.
The number indicates the primer used (Table 2) and the forward and reverse primers are labeled
with an F and R respectively. The blue blocks indicate exons while the lines connecting the exons represent
introns.

Upon initial sequencing of 18-5, three mutations were observed in the GEFmeso
sequence. However, two of the mutations are point mutations which were not observed in
the second sequencing of the same region from 18-5 homozygotes, nor were they
observed in the sequencing of the 12-5 progenitor line. A third mutation observed was an
insertion of three amino acids and was identified in two sequencing attempts of 18-5 as
well as in the sequence of 12-5.
One point mutation identified in the initial sequencing of GEFmeso is a change
from a cytosine to an adenine. This sequence alteration results in an amino acid
substitution from a proline to a threonine. The alteration is located in the amino terminal
end of the protein just 26 amino acids from the start of the protein in an unconserved
region of the protein. This proline to threonine substitution was observed only in the
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initial 18-5 sequencing reaction, and not in the second 18-5 sequencing reaction or the
sequencing of 12-5.
A second mutation is point mutation causing a change from a thymine to a
cytosine resulting in a stop codon changing to a codon coding for glutamine. This change
is significant because it ultimately results in the addition of 17 amino acids attached to
the carboxyl end of the protein which encodes a putative PDZ domain. However, this
mutation resulting in stop codon alteration was observed only in the initial sequencing
reaction of 18-5, but not in the additional sequencing reactions nor was the mutation
observed in the sequencing of 12-5.
A third mutation is a nine base-pair insertion located near the carboxyl terminal
end of the GEFmeso protein (Figure 20). The nine base-pair insertion results in a three
amino acid insertion following a valine at position 1139 of the protein sequence. The
three amino acid insertion includes an aspartic acid followed by two proline residues.
This insertion is not located within a conserved region, but was observed in four different
sequencing reactions of 18-5 and two different reactions from 12-5 (Figure 20).
Therefore, the insertion was present within the progenitor line used for the EMS screen or
the 18-5 and 12-5 mutations are the same allele of the GEFmeso gene.

Figure 20: Image showing the nine bp insertion in GEFmeso gene sequenced from 18-5 and 12-5
homozygotes (left). This insertion results in a three amino acid insertion of aspartic acid and two proline
residues into the GEFmeso protein (right).
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Genetic interaction studies place 18-5 at or above Drok in the RhoA pathway

Myosin phosphatase and slingshot mutations suppress leg and wing
malformation phenotypes exhibited by RhoA72O, +/+, 18-5 double heterozygotes.
Genetic interactions between positive regulators of the RhoA pathway typically result in
an increased level of leg and wing malformations. Recently, we have discovered
(R.Ruggiero, personal communication) that an increase in malformation caused by
mutations in two positive regulators of the pathway can be suppressed by the addition of
a third site mutation in a negative pathway regulator [55]. This assay offers an excellent
opportunity to determine where novel members of the RhoA pathway act within the
pathway (see below). In order to determine where the 18-5 locus acts in the RhoA
pathway, I utilized a third site suppression analysis.
RhoA72O is a putative null mutation resulting from the imprecise excision of a Pelement insertion into the RhoA GTPase locus [32]. 18-5 and RhoA72O interact strongly in
a heterozygous condition and exhibit wing and leg malformations (Table 8; [12]). Myosin
phosphatase negatively regulates nonmuscle myosin II through the dephosphorylation of
myosin regulatory light chain (Figure 21; [55]). The myosin binding subunit (MBS) of
myosin phosphatase regulates the catalytic subunit of myosin phosphatase in response to
upstream signals. A mutated form of Drosophila myosin binding subunit (DMbs3) is a
homozygous lethal EMS mutation. DMbs functions antagonistically to the RhoA
signaling pathway and has been shown to suppress malformation of mutations in many
RhoA pathway members including zipEbr, DRhoGEF2 and DRhoA720 [55].
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Figure 21: Model of RhoA mediated signaling in imaginal discs.

Additionally, cofilin phosphatase (ssh) acts antagonistically on the Lim kinase
side of the pathway to regulate cofilin phosphorylation, thereby regulating actin
filamentation (Figure 21; [40, 56]). 18-5 and RhoA72O trans-heterozygotes normally
express 50% leg malformation and 52% total wing malformation. The total wing
malformation can be separated into 33% general wing malformation represented by
crumpled or blistered wings and 19% exhibiting extra crossveins.
However, when a third mutation such as ssh or Mbs3 is carried by 18-5/Rho72O
trans-heterozygotes, the level of malformation is suppressed (Table 9). For example, the
addition of the ssh acts to suppress leg and wing malformation normally observed in 185/Rho72O trans-heterozygotes. In 18-5, Rho72O, and ssh triple heterozygotes, the total leg
malformation is reduced to 12% while the total wing malformation is reduced to 14%,
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approximately a four-fold suppression of each malformation (Table 9). Furthermore, in
the 18-5, Rho72O, and ssh triple heterozygotes, the percent of wings exhibiting crumpled
or blistered wings is reduced to 6% while the percent of animals exhibiting ectopic
crossveins is 8% (over 5 and 2-fold suppression respectively).
A similar pattern of suppression is observed when an Mbs mutant is used to
suppress the malformed phenotype associated with RhoA72O/18-5 trans-heterozygote
animals (Table 9). While the amount of leg malformation is similarly reduced to 12% (4fold suppression), the total wing malformation only reduced to 26% (2-fold suppression),
with 7% (5-fold suppression) exhibiting crumpled or blistered wings and no suppression
of the ectopic crossvein phenotype.
Table 9: Suppression analysis of 18-5 malformation by cofilin phosphatase (ssh) and the myosin
binding subunit of myosin phosphatase (Mbs3).
See text for discussion.
Genotype
18-5/RhoA72O
18-5/RhoA72O
18-5/RhoA72O
18-5/RhoA72O
18-5/RhoA72O; ssh/TM2
18-5/RhoA72O; ssh/TM2
18-5/RhoA72O; ssh/TM2
18-5/RhoA72O; ssh/TM2
18-5/RhoA72O; Mbs3/TM2
18-5/RhoA72O; Mbs3/TM2
18-5/RhoA72O; Mbs3/TM2
18-5/RhoA72O; Mbs3/TM2

% Malformation
(Total animals scored for leg malformation)
(Total number of individual wings scored)
50 (71 total animals scored)
52 (142 total wings scored)
33
19
12 (55)
14 (110)
6
8
12 (39)
26 (78)
7
19

Malformation type
Leg
Total malformed wing
Crumpled wing
Extra crossveins
Leg
Total malformed wing
Crumpled wing
Extra crossveins
Leg
Total malformed wing
Crumpled wing
Extra crossveins

This suppression analysis indicates that the 18-5 gene product is active within the
RhoA signaling pathway at a location even with or upstream of Drosophila Rho kinase
(Drok). Drok is a kinase which represents the branch point within the RhoA signaling
hierarchy where the signaling pathway bifurcates and results in the activation of the Lim
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kinase and myosin II heavy chain branches of the pathway (Figure 21). Moreover, this
analysis indicates that ectopic crossvein formation is regulated by the Lim kinase branch
of the pathway, whereas both branches of the RhoA pathway regulate leg malformation
and the crumpled wing phenotype.

Deficiency mapping of 12-5

Deficiencies which interact genetically with RhoA and Stubble fail to uncover
the 12-5 gene. An autosomal deletion genetic screen conducted in our laboratory to
identify genomic regions that interact with Stubble or RhoA revealed 15 deficiencies
located on the second chromosome which interact with one or the other of these loci
(Nine of which have previously been shown to complement the 12-5 mutation; Callis,
unpublished data). Because 12-5 also genetically interacts with Stubble and RhoA
mutants [12], I asked whether one of the remaining interacting deficiencies deletes the
12-5 locus. To investigate the possibility that one of these deficiencies does indeed delete
the 12-5 gene, I crossed six deficiencies that had not previously been tested with the 12-5
mutation (Table 10). Crosses were subsequently tested with 12-5 in a doubly
heterozygous condition (i.e. deficiency/+, 12-5/+). If the deficiency deletes the 12-5
locus, then the subsequent progeny carrying the deficiency and the 12-5 mutation will
exhibit malformation phenotypes and possibly show a reduction in viability similar to a
12-5 homozygote.
Crosses were set up under standard vial crosses conditions and all F1 progeny
carrying the deficiency and the 12-5 mutation were scored for malformation and reduced
viability.
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Table 10: List of deficiencies and their locations which were complementation tested with 12-5.
Crosses between female 12-5 mutants and male flies carrying deficiencies were set up under
standard vial crosses conditions and all F1 progeny carrying the deficiency and the 12-5 mutation were
scored for malformation and reduced viability. Two deficiencies, Df(2R)PC4 and Df(2R)Pu66 resulted in
reduction in viability of the animals carrying 12-5 and the deficiency compared to sibling classes.
Genotype of stock
Df(2L)net-PMF/SM6a
Df(2L)BSC16, net1 cn1/SM6a
k1

Df(2L)BSC30/SM6a, bw
Df(2L)TE35BC-24, b1 pr1 pk1 cn1
sp1/CyO
w1; Df(2R)Np5, In(2LR)w45-32n,
cn1/CyO
Df(2R)PC4/CyO
Df(2R)Pu66/CyO

Bloomington
stock number
3638

Deletion
breakpoints
21A1;21B7-8

Outcome
Complement

6608

21C3-4;21C6-8

Complement

6999

34A3;34B7-9

Complement

3588

35B4-6;35F1-7

Complement

3591
1547
6146

44F10;45D9-E1
55A1; 55F1--2
55D2; 55E2

Complement
Malformation/reduced viability
Malformation/reduced viability

Leg and wing malformation phenotypes were observed with two deficiencies on
the right arm of the 2nd chromosome. Although not fully lethal, there is a reduction in
viability of animals carrying the 12-5 mutation over deficiencies Df(2R)PC4 and
Df(2R)Pu66 (Table 11). Notably, 18-5 is nearly fully lethal over Df(2R)PC4 and many of
the 18-5/deficiency animals which survive, exhibit leg and wing malformations.

Table 11: Table showing the viability of trans-heterozygote animals involving 12-5 or 18-5.
The number represents the percent of the particular trans-heterozygotes which reach adulthood
compared to sibling classes (number in parentheses represents the total number of trans-heterozygous
animals scored). ND = not determined.
12-5/+
18-5/+
Df(2R)PC4/+
Df(2R)Pu66/+

12-5/+
10 (25)
81 (106)
60 (34)
71 (44)

18-5/+
13 (24)
12 (67)
ND
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Further mapping of the 12-5 locus

P-element recombination mapping indicates that the 12-5 gene is located
within the cytogenetic region of 50-56 of the 2nd chromosome. To confirm that the 125 locus was indeed located in the 55 cytogenetic region, I conducted P-element
recombination mapping as 12-5 mapping as described above. These experiments were
performed at low resolution so that the entire second chromosome could be tested. 12-5
mapping was conducted using the Baylor P-element mapping kit available from the
Bloomington stock center. The P-element transposons in this collection are spaced at
regular distances along the second chromosome (Table 12) and used to calculate the
recombination distances between the P-element and the 12-5 mutation.
Table 12: Recombination distances between various P-elements and 12-5.
P-element
P{SUPor-P}KG00569
P{SUPor-P}KG07698
P{SUPor-P}KG02201
P{SUPor-P}KG07111
P{SUPor-P}porin[KG09266]
P{SUPor-P}KG05572
P{SUPor-P}CG6116[KG04163]
P{SUPor-P}KG06763
P{SUPor-P}Tim17b2[KG07430]
P{SUPor-P}KG08033
P{SUPor-P}KG02815
P{SUPor-P}CG10700[KG04903]
P{SUPor-P}KG02566
P{SUPor-P}KG05308
P{SUPor-P}KG01834
P{SUPor-P}CPTI[KG01596]
P{SUPor-P}KG04872
P{SUPor-P}aPKC[KG06602]
P{SUPor-P}KG07568
y1; P{SUPor-P}KG04591/CyO, ry506
P{SUPor-P}KG07930
P{SUPor-P}KG06675
P{SUPor-P}KG06046

Bloomington
stock number
13139
15116
14423
14319
16984
13901
13360
14241
14628
14931
12989
13530
13484
14438
14580
13731
14107
14239
15114
14100
14672
14496
14470
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Cytogenetic
location
21B1
25A2
27E6
30C1
32B1
33A2
34B4
35B1
35D2
36A10
36E3
37B13
40F1
41F3
43E11
47A11
49E1
51D6
53A4
55E6
55F8
59C1
60F5

Recombination in cM
(total animals scored)
38.7 (486)
42.8 (822)
28.4 (930)
29.7 (814)
32.4 (830)
31.6 (1588)
32.2 (1247)
32.3 (788)
34.1 (1038)
29.9 (835)
28.8 (605)
27.3 (1635)
23.2 (1018)
25.4 (907)
24.3 (577)
26.6 (961)
24.2 (797)
15.7 (1358)
15.4 (762)
8.6 (961)
13.4 (1411)
27.3 (932)
34.4 (1405)

The data collected from the crosses between 12-5 and the P-elements indicates
that the mutation lies close to the 55E region where the lowest frequency of
recombination is observed (Table 12; Figure 22). A 1 cM recombination distance
between mutations within the center of the 2nd chromosome equates to approximately a
350-400 kb distance within the genome sequence. Although the resolution of this initial
P-element recombination mapping is inadequate for the precise location of the 12-5 locus
this data indicates that the 12-5 mutation is located in an interval of approximately 2.6
Mb near the 55E cytogenetic location (Figure 22). Further molecular mapping is required
to identify the precise locus of the 12-5 mutation.
Location
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Figure 22: Schematic of the second chromosome and the P-elements used to map 12-5.
The schematic represents the P-elements located along the 2nd chromosome. The boxes in light
blue depict the cytogenetic location of each insertion while the white boxes below indicate the percentage
of recombination between each P-element and 12-5. The dark blue box represents the centromere.

12-5 genetic interactions

Similar to the 18-5 mutation, 12-5 interacts genetically with mutations in
RhoA, Cdc42, and Lim kinase and exhibits weak interactions with mutations in Egfr
and Pak, but not with blistered, Rgl, or Rlip mutants. I conducted second-site noncomplementation tests between 12-5 and mutations in genes listed in table 13 in order to
characterize the functional relationship between 12-5 and various mutations that possibly
play a role in leg and wing epithelial morphogenesis. Because 12-5 also exhibits ectopic
crossvein phenoytpes that are similar to the 18-5 mutant, it was important to investigate
possible genetic interactions between 12-5 and many the same mutant alleles tested for
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interactions with 18-5 (Table 13). The results show that 12-5 interacts weakly with Egfr,
Cdc42, Lim kinase, and Pak, but does not exhibit any malformation phenotype with
blistered (Table 13).
I also investigated the genetic interactions between 12-5 and 18-5 and 12-5 and
RhoA, in an effort to more thoroughly examining ectopic crossvein expression. I found
that 12-5 interacts strongly with both 18-5 and RhoA72O with respect to ectopic crossvein
formation. The trans-heterozygote 12-5/18-5 and 12-5/RhoA72O F1 progeny exhibit
ectopic crossvein phenotypes (43% and 16% respectively) as well as leg (17% and 51%
respectively) (Table 13).
Finally, I analyzed the 12-5 genetic interactions with two deficiencies located in
the 55DE region, Df(2R)Pu66 and Df(2R)PC4. I found that 12-5 interacts strongly with
both deficiencies exhibiting severe leg and wing malformations (Table 13). Interestingly,
Df(2R)Pu66 and Df(2R)PC4 have been shown to delete the 18-5 locus (Callis and von
Kalm, unpublished data and see above) Overall, the genetic interactions are remarkably
similar to the genetic interactions observed in the 18-5 mutation.
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Table 13: Genetic interactions of the 12-5 mutation.
All stocks shown were crossed to 12-5/CR2 and the trans-heterozygotes carrying the 12-5
mutation and the mutation in the gene of interest were scored for leg and wing malformation. Numbers
indicate the percent malformation observed in the trans-heterozygotes (number in parentheses indicates the
total animals and wings scored).
Malformation

Genotype of Stock/Cross
(Oregon R)+/+
w, 12-5/CyH
18-5/CR2*
Df(2R)Pu66/CR2*
Df(2R)PC4/CR2*

Gene of
Interest
Wildtype
12-5
18-5
18-5
18-5

Leg total
(total animals
scored)
0 (71)
80 (25)
17 (106)
17 (44)
49 (34)

Crumpled
wing
0
36
46
17
36

Extra
crossveins
0
54
43
58
53

Wing total
(total wings
scored)
0 (142)
90 (50)
89 (212)
75 (88)
89 (68)

Rho72O/CyO

RhoA

51 (71)

35

16

51 (142)

y,w{P[Limk1,EYO8757]}

LimK

3 (236)

8

17

25 (472)

Pak6/TM3,Sb1
Pak11/TM3,Sb1

Pak
Pak

0 (29)
0 (28)

3
0

0
0

3 (58)
0 (56)

y,w,Cdc424P{ry[+t7.2]=neoFRT}/FM6

Cdc42

0 (27)

0

17

17 (54)

w67C23 P{lacW}RalaG0174/ FM7c

Rala

0 (26)

0

0

0 (52)

Rala

0 (17)

0

0

0 (34)

P{GT1}RglBG02025/ TM3,Sb1,Ser1

Rgl

0 (44)

0

0

0 (88)

Df(2R)Egfr18, b[1] pr, cn,/CyO

Egfr

7 (15)

8

0

8 (30)

Egfr
Egfr
Egfr
Egfr

0 (49)
0 (39)
0 (29)
0 (64)

0
0
0
0

0
0
0
0

0 (98)
0 (78)
0 (58)
0 (128)

67c23

w

t1

G0373

P{lacW}Rala

1

/ FM7c

Egfr bw /CyO
cn[1] Egfr[f2] bw[1] sp[1]/CyO
Egfr[f24]/T(2;3), CyO: TM6B, Tb[1]
y w; P{lacW}Egfr[k05115]/CyO
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DISCUSSION

Understanding the general mechanisms regulating epithelial morphogenesis is
fundamental to the understanding the pathology of epithelia. Drosophila leg imaginal
discs are an excellent system in which to study the basic principles of epithelial
morphogenesis. Drosophila imaginal primordia give rise to most of the adult epithelial
structures including the adult head, thorax and appendages, and external genitalia.
Imaginal discs arise as invaginations of embryonic epithelium and grow by mitosis until
metamorphosis, at which time substantial morphological changes occur. In leg imaginal
discs, these morphological changes are coordinated by precise cell shape changes [9, 10,
19]. These cell shape changes act to guide the morphogenesis of many tissues and organs.
Specifically, in Drosophila, correct epithelial morphogenesis is crucial for the
development of legs and wings.
A number of genes controlling cell shape changes and presumably actin-myosin
contractility are associated with the proper development of the Drosophila adult leg and
wing. Two gene groups influencing leg and wing epithelial morphogenesis include the
ecdysone hormone responsive genes and genes that are not directly regulated by
ecdysone [11, 12, 21-23, 25, 49].
Three studies have provided evidence for ecdysone and RhoA mediated pathways
acting in a coordinated effort to regulate imaginal disc epithelial morphogenesis [11, 12,
48]. Consequently, the genes which interact genetically with both the ecdysone and RhoA
pathway members are key to deciphering the regulatory mechanism guiding leg and wing
epithelial morphogenesis. The 18-5 and 12-5 genes identified by our lab are significant in
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that they have been shown to interact with both ecdysone activated Stubble locus as well
as RhoA pathway members. The goal of this research is to gain a better understanding of
18-5 and 12-5 in order to help elucidate the mechanism of interaction of steroid hormone
and intracellular signaling regulating the process of epithelial morphogenesis.
To identify the 18-5 and 12-5 genes I utilized a P-element recombination mapping
technique to identify the precise location of these genes within the Drosophila genome
[50]. Using this technique I have narrowed the molecular location of the 18-5 locus to an
interval of 112 kb within the Drosophila genome. This 112 kb region contains 17 known
and predicted genes. Additionally, I have also narrowed the location of the 12-5 mutation
to a 2.6 Mb interval on the right arm of the 2nd chromosome.
Phenotypic and mapping analysis identified a candidate gene for the 18-5
mutation. This candidate gene was recently identified as a Ral GEF named GEFmeso
[53]. Significantly, RNAi experiments targeting GEFmeso identified a mutant ectopic
crossvein phenotype which is similar to that observed in 18-5 homozygotes. Moreover,
GEFmeso has been shown to bind Cdc42 [53], a gene with which 18-5 interacts (Figure
17). Therefore, I cloned and sequenced GEFmeso from 18-5 and 12-5 (as progenitor
controls) homozygotes. The sequencing results were inconclusive and require further
analysis.
In order to further characterize the functions of the 18-5 and 12-5 loci, genetic
interaction studies were performed. I found that 18-5 and 12-5 genetically interact with
mutations in LIM kinase, but do not interact genetically with Pak, blistered (DSRF), or
Ral GTPase. A gene known to play a role in longitudinal vein formation, Egfr [57],
exhibited only minor genetic interactions with 18-5 and 12-5. Furthermore, I have shown
that 18-5 and 12-5 interact with Cdc42 and exhibit ectopic wing crossveins. However,
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animals heterozygous for 18-5, 12-5, or Cdc42 mutations do not show any leg
malformation or crumpled wing phenotypes.
Finally, to better understand the role of 18-5 within the RhoA signaling hierarchy,
I have also conducted third site suppression analysis studies. I tested triple mutants
carrying 18-5, RhoA720 and Mbs3 (all in heterozygous condition) as well as 18-5, RhoA720
and ssh (also all in heterozygous condition). Myosin phosphatase (Mbs) and Slingshot
(ssh) act antagonistically to regulate the RhoA signaling pathway [40, 55, 58].
Interestingly, the addition of third site mutations Mbs and ssh suppressed the leg and
crumpled wing phenotypes normally exhibited in 18-5/RhoA72O trans-heterozygotes.
However, the ectopic crossvein phenotype was only suppressed in combinations carrying
a ssh mutation. This analysis indicates that with respect to most aspects of leg and wing
morphogenesis, 18-5 acts at or above Drok in the RhoA pathway and that crossvein
formation is regulated by the Limk/ssh branch of the pathway.

Deficiency and recombination mapping of 18-5

The P-element recombination mapping of 18-5 considerably narrowed the region
in which it is located and as well as the number of possible gene candidates. The 55C955D4 region of the 2nd chromosome contains a total of 17 genes. One discrepancy
between the recombination and deficiency data is that the recombination data mapped the
18-5 mutation to a region approximately 75 kb upstream from the left breakpoint of the
smallest deficiency to uncover 18-5. This data interpreted literally, suggests that the
mutation was mapped with deficiencies to the 55D region as well as further upstream to
55C9-11 by recombination mapping.
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The most likely explanation for this discrepancy is that the P-elements used for
mapping were not close enough to the 18-5 locus to obtain sufficiently accurate
resolution. Zhai et, al. (2003) achieved resolution to within 50 kb in situations where
fewer than 10 recombinants per 10000 progeny were observed. In contrast, in my
experiments, the lowest number of recombinants was 120 per 10,000 animals. This would
presumably result in a decrease in resolution of the mapping recombination rate, thereby
decreasing the accuracy of the mapping technique. In view of these limitations, resolution
to within 75 kb of the closest deficiency breakpoint seems reasonable.
The resolution could be increased through several methods. We could possibly
create a new 18-5 allele with EMS which would exhibit either full lethality or exhibit a
stronger mutant phenotype for scoring the escapers. Another option would be to utilize Pelements which are closer to the 18-5 locus. The nearest P-elements used in my
experiments were approximately 350 kb away from the projected location of the 18-5
locus. The reason for choosing these P-elements was to ensure that we utilized Pelements located to the left and right of the mutation. Choosing P-elements which are
located at a distance of 100-150 kb away from the 18-5 locus would increase the
resolution of the molecular mapping. Finally, another method for increasing the
resolution would be to increase the number of crosses and animals scored. This would
decrease the affect the escapers have on the overall calculations.
To further elucidate the cause of the difference between the molecular mapping
and P-element recombination data, I used several lethal insertions to more clearly identify
the precise endpoints of the deficiencies. The deficiency Pu66 deletes the genomic region
of 55D2-55E4. In an effort to determine if Df(2R)Pu66 actually deletes a portion of the
chromosome further to the left of the published breakpoint, I crossed two lethal P57

elements located at 55C9 and 55D1 to the deficiency. The data obtained indicate that the
Pu66 deficiency had a left breakpoint which did not extend further upstream than 55D2.
This results in three possible interpretations. First, this indicates that the
resolution of the molecular mapping resulted in an incorrect position of the 18-5 mutation
and the 18-5 locus is actually located within the region of the deficiency Df(2R)Pu66. A
second interpretation is that the molecular mapping correctly positioned the 18-5 locus,
but the deficiency deletes a gene which when carried as a trans-heterozygote with 18-5
results in reduced viability and characteristic leg and wing malformations. Finally, the
chromosome carrying the deficiency could possibly carry an additional mutation outside
of the deleted region which acts similarly to reduce viability and cause the resultant
malformation phenotypes. Clearly, further mapping experiments are needed to precisely
locate the 18-5 gene. These could include either the P-element recombination mapping
with necessary modifications, or possibly using another method such as the male Pelement recombination technique [59] which positions a gene to the right or left of a Pelement.

18-5 genetic interactions

While 18-5 heterozygotes do not exhibit leg or wing malformation, 18-5
homozygous mutants often exhibit the characteristic leg malformations represented by
shortened, twisted femurs (67%). Also, 18-5 homozygotes exhibit 81% overall wing
malformation, of which, 50% are crumpled or blistered and 31% exhibit ectopic
crossveins. 18-5 also interacts genetically with ecdysone activated Sb (34-37%) and
RhoA pathway members such as RhoA (72-81%) and zipper (41%) [12]. I have futher
identified 18-5 genetic interactions with an additional RhoA pathway member, Lim
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kinase. 18-5/Lim kinase trans-heterozygotes exhibit a weak genetic interaction exhibiting
11% total wing malformation. Additionally, suppression analysis places the 18-5 gene
product within the RhoA signaling pathway at or above Drok (Table 9; Figure 21). This
genetic evidence strongly suggests a role for 18-5 in the interaction of ecdysone activated
stubble and RhoA regulation of leg and wing morphogenesis.
Of particular interest a malformation phenotype often observed in 18-5
homozygotes is the induction of ectopic crossveins (31%). Significantly, ectopic
crossveins have also been exhibited in mutations in Cdc42, Lim kinase as well as RNAi
experiments targeting GEFmeso [48, 51-53]. To investigate the role of 18-5 in the
development of wing crossveins, I conducted many crosses specifically analyzing ectopic
crossvein expression. I observed ectopic wing crossveins in 18-5/RhoA (19%) and 185/12-5 (43%) trans-heterozygotes. Interestingly, 18-5/Lim kinase trans-heterozygotes
exhibit a weak (8%) genetic interaction regarding ectopic wing crossveins, and 185/Cdc42 trans-heterozygotes show weak (9%) to strong (53%) interactions regarding
ectopic wing crossveins. Finally, third site suppression analysis indicates that ectopic
crossvein formation is regulated by the Lim kinase branch of the pathway (Table 9;
Figure 21).

GEFmeso

GEFmeso is a recently identified Drosophila Ral guanine exchange factor [53]. It
has been shown to bind Cdc42 as well as DRal GTPase. Furthermore, in RNAi
experiments targeting GEFmeso, investigators found an increase in ectopic crossvein
formation. This phenotype has been observed in mutants of several other genes including,
Cdc42, Egfr, RhoA, Sb, and Lim kinase (Table 8; [48, 51-53]. The ectopic crossvein
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phenotype has also been observed in 18-5 (31%) and 12-5 (54%) homozygotes.
Additionally, the GEFmeso gene is located within the Df(2R)Pu66 deficiency. This
information suggested that GEFmeso was a good candidate to be the 18-5 locus. I tested
this hypothesis by sequencing the gene from 18-5 homozygotes. Although the sequencing
data for GEFmeso were inconclusive, they do not rule out GEFmeso as a candidate at this
point. The initial sequencing identified three mutations (discussed below). Further
analysis is required to fully elucidate potential sequence alterations in the GEFmeso gene
of 18-5 homozygotes.
Proline to threonine: The initial sequencing of 18-5 identified an amino acid
change from a proline to a threonine. Although this amino acid change was not observed
in the second sequencing reaction, it remains to be investigated if indeed it is a bona fide
alteration to the sequence. This amino acid change could be of importance to the protein
because threonine residues are susceptible to phosphorylation which could alter the
conformation and hence, the catalytic activity of the protein. Although the putative
proline to threonine substitution is not in a highly conserved domain such as the DH, PH
or Ral binding region, if phosphorylated, it could potentially disrupt the activity of the
protein.
Termination codon alteration: A second mutation found in the initial
sequencing, but not observed in the second sequencing of 18-5 is the change of a stop
codon to a codon coding for a glutamine. The change of a stop codon to a glutamine
results in the lengthening of the protein by 17 amino acids. Recall that the C-terminus of
GEFmeso is thought to contain a PDZ domain. The PDZ domain is responsible for
protein interactions. An addition to the C-terminus could alter the protein-protein binding
of the GEF and interrupt specific localization of the protein needed for correct function.
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Insertion: The three amino acid insertion at location 1139 of the 1239 amino acid
protein is not located in any region of the protein that is relevant to binding or activation,
however, it does occur near a proline rich region and the putative PDZ domain at the
carboxyl end of the protein. However, the insertion was also observed in 12-5
homozygotes as well as 18-5 homozygotes, indicating that it existed in the progenitor
stock from which the 18-5 and 12-5 mutations were isolated (Figure 20).
Further sequence analysis must be completed before ruling out GEFmeso as a
candidate for the 18-5 mutation. First, in the unlikely event that the initial sequencing of
18-5 revealed a true mutation, and the second sequencing reactions revealing a wildtype
sequence were incorrect, I will sequence the relevant regions a third time to verify the
results. Furthermore, I could sequence a third member of the progenitor line, 31-6, to
compare to the initial sequencing of GEFmeso in 18-5 mutants. An alternative would be
to determine if GEFmeso RNA is altered in quantity or size in the 18-5 mutant. Finally,
another approach would be to conduct rescue experiments using genomic fragments from
within the 112 kb region.

Possibility that 18-5 and 12-5 are alleles warrants additional analysis

The 12-5 mutation exhibits many similarities to the 18-5 mutation raising the
possibility that 12-5 is allelic to 18-5. Although the possibility is speculative at this time,
the evidence supporting the possibility warrants further investigation.
Genetic interactions: 18-5 and 12-5 both interact strongly with RhoA, and
weakly to moderately with zip and Sb (Table 1; [12]. Additionally, 18-5 and 12-5 also
exhibit similar genetic interactions regarding ectopic crossvein expression with LIM
kinase (8% and 17% respectively), and both 18-5 and 12-5 each express ectopic
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crossveins (17% for both mutations) as trans-heterozygotes with Cdc424. Furthermore,
12-5 and 18-5 mutants both exhibit strong genetic interactions and reduced viability with
the deficiency Df(2R)PC4. Altogether, this data raises the possibility that the 12-5
mutation is an allele of 18-5 however, further genetic interaction studies are necessary.
Pupal lethality and reduced viability: The 18-5 and 12-5 mutants both exhibit
pupal lethality as homozygotes (Callis and von Kalm, data not shown), and as reported
here and by Bayer et, al (2003), the 18-5 +/+ 12-5 double heterozygotes show reduced
viability. The reduced viability (only 81% reach adulthood) of the double heterozygotes
also is suggestive of lethality during pupal phase development.
Molecular mapping: 18-5 has been narrowed to the interval of 55C9-10-55D4
and preliminary evidence suggests that 12-5 could be mapping to the same locus.
Interestingly, the 12-5 mutation was mapped to a cytogenetic region near 55E of the
Drosophila genome. However, further mapping must be conducted to narrow the 12-5
mapping interval as many genes are located in this region of the Drosophila genome
including genes encoding RhoA GTPase and Myosin light chain kinase. Altogether, this
evidence, although not concrete, is supportive of the possibility that 12-5 and 18-5 are
alleles and warrants further analysis.

Broader Significance

Several recent studies have identified an interesting intersection between systemic
ecdysone steroid hormone signaling and the cell autonomous intracellular RhoA
signaling pathway [11, 12, 25, 27]. Currently there is a major gap in the understanding of
how systemic hormone signals regulate intracellular signaling pathways during
development. For example, estrogen and progesterone have been shown to play an
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important role in the sprouting morphogenesis occurring during alveologenesis in
mammary gland development of rats and mice [17]. Estrogen and progesterone activate
genes such as IGF-1 and Wnt-4 via a mechanism that is poorly defined. IGF-1 and Wnt-4
are necessary for correct branching morphogenesis of the developing mammary gland,
however, the specific pathways activated by these growth factors has not been established
[16]. In the developing murine urethra, androgenic hormones regulate Fgfr, which is
essential for the development of the urethral tube [4]. However the mechanism by which
Fgfr is activated is again poorly understood, and although Fgfr is presumed to activate
Receptor Tyrosine Kinase signaling, this has not been demonstrated.
In a vertebrate system somewhat analogous to Drosophila leg development,
murine prostate gland development has been shown to be regulated by androgenic
hormones. Interestingly, studies have shown that during prostate gland development,
androgenic hormones regulate the TMPRSS2 type II transmembrane serine protease [44].
Although the function of TMPRSS2 has not been fully elucidated at this time, the TTSP
is proteolytically autoactivated in response to androgenic hormones and regulates
intracellular signaling via PAR2 [44]. Significantly, TMPRSS2 is highly expressed in
prostate as well as colonic cancers indicating that elucidation of the mechanism of
hormonally induced intracellular signaling role by TMPRSS2 is a question of
considerable clinical significance. In this context it is also clear that understanding the
nature of the interaction between ecdysone and intracellular signaling pathways in
Drosophila imaginal discs is likely to contribute in a fundamental way to a broader
understanding of hormonal involvement in vertebrate development and pathology.
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Future Directions

Identification of the 18-5 gene product: If it is concluded upon additional
GEFmeso sequencing, that GEFmeso is not 18-5, then different strategies must be
utilized to identify the 18-5 gene. Additional P-element recombination mapping is not an
ideal method due to the difficulties in separating white eye recombinants from white eye
non-recombinants (see methods). Therefore, alternative approaches must be applied to
identify the 18-5 gene. One strategy to consider will be to create designer deletions with
hobo elements to better define the region containing the 18-5 gene. Overlapping deletions
created by the imprecise excision of hobo elements located less than 200 kb from the 185 locus would help determine the precise region in which 18-5 is located. Additionally,
presuming that there is a reduction in size or quantity of 18-5 RNA, we could analyze the
RNA expression of the genes located in the small region narrowed down by the
molecular mapping. We will conduct northern blots of genes of wildtype flies and
compare the expression patterns to the same genes from 18-5 homozygotes. Finally
another technique is to conduct genomic rescue of the 18-5 malformation phenotype.
This technique would allow us to take approximately 10 kb fragments across the 150 kb
region and use them for genomic rescue of the mutant phenotype.
Phenotypic characterization of 18-5: Further characterization of the 18-5
phenotype will improve our understanding of the role of 18-5 in Drosophila
development. For example, investigations into the role of 18-5 in embryonic, larval and
pupal phase development will lead to a better understanding of the spatial and temporal
aspects of 18-5 in Drosophila development. Additionally, once the gene product is
known, we will be able to formulate a hypothesis to test the role of 18-5 in RhoA
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signaling, however, experiments to be conducted at this point remain contingent upon the
actual 18-5 gene product. Finally, we will conduct experiments to determine whether 185 gene is ecdysone responsive.
18-5 Genetic interactions: Further experiments are needed to investigate the
genetic relationships between 18-5 and other genes with a role in the development of
Drosophila legs and wings and in particular wing crossvein development. For example,
further investigation of possible interactions between 18-5 and Cdc42, Pak, and Lim
kinase must be conducted for a better understanding of the respective genetic
relationships regarding wing crossvein development. For example, Pak is a downstream
effector of Cdc42 and furthermore, Pak has been shown to activate Lim kinase. This
represents a possible signaling pathway regulating wing crossvein development. I have
shown that 18-5 interacts genetically with Cdc42 and Lim kinase with the respective
trans-heterozygotes exhibiting ectopic wing crossveins.
Therefore it is important to further investigate the genetic relationships between
18-5 and Cdc42, Pak and Lim kinase, because this represents a possible RhoA-Cdc42
connection involving crosstalk between the Cdc42 and RhoA GTPase signaling
hierarchies (see figure 21). Interestingly, Cdc42 does not interact with RhoA or other
members of the RhoA signaling pathway in leg development. However, Cdc42 interacts
with Lim kinase and 18-5 and RhoA interacts with Sb and 18-5 in wing crossvein
development. It remains to be tested whether RhoA interacts with other members of the
RhoA pathway or Cdc42 in wing crossvein development. Further experiments
investigating this apparent signaling network are needed to fully understand the role of
18-5 in RhoA signaling. Finally, if GEFmeso is indeed 18-5, then this genetic interaction
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data should help understand the role of this Guanine nucleotide exchange factor in the
developing leg and wing.
12-5 mapping: The rough mapping of the 12-5 locus narrowed the region
significantly, but further mapping experiments remain necessary to clearly identify the
12-5 gene. This mapping will be conducted using the P-element recombination mapping
technique used to map 18-5 (see methods). If the additional P-element recombination
mapping fails to identify the 12-5 gene locus, then we will utilize the alternative
techniques described for the identification of 18-5 in the case that GEFmeso is not 18-5.
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